FPH:NYSEFive Point Holdings, LLC Analysis
Data as of 2026-04-04 - not real-time
$4.90
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Five Point Holdings (FPH) trades at $4.90, well below its DCF‑derived fair value of $6.13, indicating a sizable discount. The stock sits beneath its 20‑day (5.02), 50‑day (5.27) and 200‑day (5.69) simple moving averages, confirming a bearish price trend. Relative strength index at 38.9 points suggests the shares are approaching oversold territory, but momentum remains weak. MACD shows a bearish crossover with the histogram turning negative, reinforcing short‑term downside pressure. Fundamentally, the company reports a PE ratio of 5.1 versus an industry average of 32, and a price‑to‑book of 0.41, underscoring deep value. However, revenue has collapsed by 52.5% year‑over‑year, and free cash flow is negative, highlighting operational challenges.
The balance sheet carries $518 M of debt against $425 M of cash, resulting in a high debt‑to‑equity ratio and limited financial cushion. Insider activity added pressure as the chief policy officer sold $580 k of stock at $5.23, signalling possible concerns. Volatility over the past 30 days is elevated at 24 %, and while beta is sub‑1, the real‑estate development sector is inherently cyclical. Support is identified near $4.72 and resistance near $5.50, placing the current price within a narrow trading range. Upcoming earnings for Q4 2025 could provide clarity on whether the revenue decline is temporary or structural. Given the valuation discount, the stock may reward investors who can tolerate short‑term weakness in exchange for potential long‑run upside.
The balance sheet carries $518 M of debt against $425 M of cash, resulting in a high debt‑to‑equity ratio and limited financial cushion. Insider activity added pressure as the chief policy officer sold $580 k of stock at $5.23, signalling possible concerns. Volatility over the past 30 days is elevated at 24 %, and while beta is sub‑1, the real‑estate development sector is inherently cyclical. Support is identified near $4.72 and resistance near $5.50, placing the current price within a narrow trading range. Upcoming earnings for Q4 2025 could provide clarity on whether the revenue decline is temporary or structural. Given the valuation discount, the stock may reward investors who can tolerate short‑term weakness in exchange for potential long‑run upside.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Bearish technical indicators (price below SMAs, negative MACD)
- Proximity to support level at $4.72
- Recent insider share sale
Medium Term
1–3 yearsPositive
Model confidence: 6/10
Key Factors
- Significant valuation discount to DCF fair value
- Low PE and P/B ratios relative to industry
- Potential earnings rebound after Q4 2025 results
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Long‑term land banking assets in high‑growth California markets
- Undervalued balance sheet with ample cash relative to debt
- Strategic position in mixed‑use development that could benefit from housing demand
Key Metrics & Analysis
Financial Health
Revenue Growth-52.50%
Profit Margin64.50%
P/E Ratio5.1
ROE8.03%
ROA-0.14%
Debt/Equity21.69
P/B Ratio0.4
Op. Cash Flow$105.2M
Free Cash Flow$-107068624
Industry P/E32.0
Technical Analysis
TrendBearish
RSI38.9
Support$4.72
Resistance$5.50
MA 20$5.02
MA 50$5.27
MA 200$5.69
MACDBearish
VolumeStable
Fear & Greed Index78.8
Valuation
Fair Value$6.13
GradeUndervalued
TypeValue
Risk Assessment
Beta0.78
Volatility24.12%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.